Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03146390Phase 4Unknown
Phase 4, randomised trial of Listerine Zero in dental plaque (3 arms), sponsored by Universidad de Santiago de Compostela. Primary endpoints: Change in the Bacterial viability (%) (substantivity) at 7 hours, Bacterial viability (%) (antiplaque effect) and 3 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03146390.